VMP 41790611000001106

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Leflunomide 20mg tablets
BNF code 1001030L0AAABAB
Virtual Therapeutic Moiety Leflunomide
Date identifier became valid 12 May 2023
Previous product identifier 330058002
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Leflunomide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 20.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Arava 20mg tablets (CST Pharma Ltd)
Arava 20mg tablets (Sanofi)
Arava 20mg tablets (Sigma Pharmaceuticals Plc)
Leflunomide 20mg tablets (A A H Pharmaceuticals Ltd)
Leflunomide 20mg tablets (Alliance Healthcare (Distribution) Ltd)
Leflunomide 20mg tablets (Aspire Pharma Ltd)
Leflunomide 20mg tablets (Medihealth (Northern) Ltd)
Leflunomide 20mg tablets (Relonchem Ltd)
Leflunomide 20mg tablets (Sandoz Ltd)
Leflunomide 20mg tablets (Sigma Pharmaceuticals Plc)
Leflunomide 20mg tablets (Tillomed Laboratories Ltd)
Leflunomide 20mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Leflunomide 20mg tablets 100 tablet
Leflunomide 20mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback